Rua Bioscience Shareholder Newsletter March 2022

Today Rua Bioscience (NZX: RUA) released its Shareholder Newsletter.

As well as being a recap of Rua's top stories, you’ll find other information that will give you insight into the industry, the broader market, and the way Rua conducts itself as a company committed to creating cannabinoid-based medicines that change people’s lives.

In this issue:
- The Zalm acquisition
- Medsafe’s approval of our first product
- The merging of two kaupapa: Rua and E3C’s landmark grower partnership
- Farm to pharmacy innovation
- Umanga, our upcoming careers series
We also introduce you to some of our team.

For further information, please contact:
Kerry Donovan
Rua Bioscience Communications Manager
[email protected]

---

Announcement PDF